Status:
COMPLETED
Saccadic Eye Movements in Patients With Niemann-Pick Type C Disease
Lead Sponsor:
National Eye Institute (NEI)
Conditions:
Niemann Pick Diseases
Eligibility:
All Genders
12+ years
Phase:
PHASE1
Brief Summary
This study is done in conjunction with a trial, conducted at Columbia University College of Physicians and Surgeons in New York and the Royal Manchester Children's Hospital in England, to examine the ...
Detailed Description
None given, verified by PI.
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Patients with NPC disease confirmed by abnormal cholesterol esterification and abnormal filipin staining.
- Patients aged 12 and over. Body weight must not be less than 14 kg.
- Patients who can ingest a capsule.
- EXCLUSION CRITERIA:
- Patients younger than 18 who are unable to give informed assent and/or whose legal guardian is unable to provide informed consent.
- Patients aged 18 and over who cannot provide informed consent and/or whose legal guardian is unable to provide witnessed informed consent.
- Fertile patients who do not agree to use adequate contraception throughout the study and for three months after cessation of OGT 918 treatment.
- Patients who cannot tolerate the study procedures or who are unable to travel to the study center as required by this protocol.
- Patients currently undergoing therapy with other investigational agents or patients taking drugs or food supplements which may interfere with gastrointestinal absorption or motility.
- Patients suffering from clinically significant diarrhoea (greater than 3 liquid stools per day for greater than 7 days) without definable cause within 3 months of Screening Visit, or who have a history of significant gastrointestinal disorders.
- Patients with an intercurrent medical condition that would render them unsuitable for the study e.g. HIV, hepatitis infection.
- Patients who in the opinion of the investigator (for whatever reason) are thought to be unsuitable for the study.
Exclusion
Key Trial Info
Start Date :
October 17 2002
Trial Type :
INTERVENTIONAL
End Date :
August 15 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00316498
Start Date
October 17 2002
End Date
August 15 2007
Last Update
July 2 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
2
Columbia University
New York, New York, United States, 10032-3784
3
Oxford GlycoSciences Ltd.
Abingdon, United Kingdom